MA 19.03 Nintedanib + Pemetrexed/Cisplatin in Malignant Pleural Mesothelioma (MPM): Phase II Biomarker Data from the LUME-Meso Study
Year: 2017
Type: article
Source: Journal of Thoracic Oncology
Institutions: The University of Western Australia, Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Beatson West of Scotland Cancer Centre, University of Turin, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Austin Hospital, Olivia Newton-John Cancer Research Institute, Princess Margaret Cancer Centre, German Center for Lung Research, LungenClinic Grosshansdorf, Northern Cancer Institute, Rigshospitalet, Institut Gustave Roussy, Fondation Gustave Roussy, Humanitas Gavazzeni, Prince Charles Hospital, Hôpital Larrey, University of Pittsburgh, Boehringer Ingelheim (Germany)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2767823820